The neutrophil to lymphocyte ratio in heart failure: a comprehensive review
Authors:
Open Access
- 1 December 2019
- journal article
- review article
- Published by Walter de Gruyter GmbH in Romanian Journal of Internal Medicine
- Vol. 57 (4) , 296-314
Abstract
Introduction. Heart failure (HF) and systemic inflammation are interdependent processes that continuously potentiate each other. Distinct pathophysiological pathways are activated, resulting in increased neutrophil count and reduced lymphocyte numbers, making the neutrophil to lymphocyte ratio (NLR) a potential indirect marker of severity. We conducted this comprehensive review to characterize the role of NLR in HF. Methods. We searched the PubMed (MEDLINE) database using the key words “neutrophil”, “lymphocyte”, “heart failure”, “cardiomyopathy”, “implantable cardioverter defibrillator”, “cardiac resynchronization therapy” and “heart transplant”. Results. We identified 241 publications. 31 were selected for this review, including 12,107 patients. NLR was correlated to HF severity expressed by clinical, biological, and imaging parameters, as well as to short and long-term prognosis. Most studies reported its survival predictive value. Elevated NLR (>2.1–7.6) was an independent predictor of in-hospital mortality [adjusted HR 1.13 (95% CI 1.01–1.27) – 2.8 (95% CI 1.43–5.53)] as well as long-term all-cause mortality [adjusted HR 1.43 (95% CI 1.1–1.85) – 2.403 (95% CI 1.076–5.704)]. Higher NLR levels also predicted poor functional capacity [NLR > 2.26/2.74, HR 3.93 (95% CI 1.02–15.12) / 3.085 (95% CI 1.52–6.26)], hospital readmissions [NLR > 2.9/7.6, HR 1.46 (95% CI 1.10–1.93) / 3.46 (95% CI 2.11–5.68)] cardiac resynchronization therapy efficacy [NLR > 3.45/unit increase, HR 12.22 (95% CI 2.16–69.05) / 1.51 (95% CI 1.01–2.24)] and appropriate implantable cardioverter defibrillator shocks (NLR > 2.93), as well as mortality after left ventricular assist device implantation [NLR > 4.4 / quartiles, HR 1.67 (95% CI 1.03–2.70) / 1.22 (95% CI 1.01–1.47)] or heart transplant (NLR > 2.41, HR 3.403 (95% CI 1.04–11.14)]. Conclusion. Increased NLR in HF patients can be a valuable auxiliary biomarker of severity, and most of all, of poor prognosis.Keywords
This publication has 48 references indexed in Scilit:
- Inflammatory Markers-Serum Level of C-Reactive Protein, Tumor Necrotic Factor-α, and Interleukin-6 as Predictors of Outcome for Peripartum CardiomyopathyThe Journal of Obstetrics and Gynecology of India, 2013
- Positioning of Inflammatory Biomarkers in the Heart Failure LandscapeJournal of Cardiovascular Translational Research, 2013
- Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapyMedical Science Monitor, 2013
- Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection FractionCirculation: Heart Failure, 2012
- The immunological axis in heart failure: importance of the leukocyte differentialHeart Failure Reviews, 2012
- Usefulness of Total Lymphocyte Count as Predictor of Outcome in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2011
- Utility of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Outcomes in Acute Decompensated Heart FailureThe American Journal of Cardiology, 2011
- Neutrophilia Predicts Death and Heart Failure After Myocardial InfarctionCirculation: Cardiovascular Quality and Outcomes, 2009
- Activation of polymorphonuclear neutrophils in patients with impaired left ventricular functionFree Radical Biology and Medicine, 2007
- Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.Journal of Clinical Investigation, 1990